Show simple item record

dc.contributor.authorCole, Thomas O
dc.contributor.authorRobinson, Darlene
dc.contributor.authorKelley-Freeman, Andrea
dc.contributor.authorGandhi, Devang
dc.contributor.authorGreenblatt, Aaron D
dc.contributor.authorWeintraub, Eric
dc.contributor.authorBelcher, Annabelle M
dc.date.accessioned2021-02-17T21:31:19Z
dc.date.available2021-02-17T21:31:19Z
dc.date.issued2021-01-21
dc.identifier.urihttp://hdl.handle.net/10713/14703
dc.description.abstractTelemedicine is increasingly being used to treat patients with opioid use disorder (OUD). It has particular value in rural areas of the United States impacted by the opioid crisis as these areas have a shortage of trained addiction medicine providers. Patient satisfaction significantly impacts positive clinical outcomes in OUD treatment and thus is of great clinical interest. Yet little is known regarding patient satisfaction with the increasingly important platform of telemedicine-delivered medications for opioid use disorder (tMOUD). The goal of this review is to provide a summary of the existing literature regarding patient satisfaction with tMOUD. We also submit a novel survey based on an existing framework designed to assess tMOUD satisfaction, and present pilot data (N = 14) acquired from patients engaged in rural tMOUD care. Telemedicine provides a feasible method for delivering MOUD in rural areas, and our survey provides a useful assessment to measure patient satisfaction with tMOUD. In light of the pressing need for innovative and technology-driven solutions to the opioid epidemic (especially in light of the COVID-19 pandemic), future research should focus on the development and refinement of tools to assess the important implementation goal of patient satisfaction.en_US
dc.description.urihttps://doi.org/10.3389/fpubh.2020.557275en_US
dc.language.isoenen_US
dc.publisherFrontiers Media S.A.en_US
dc.relation.ispartofFrontiers in Public Healthen_US
dc.rightsCopyright © 2021 Cole, Robinson, Kelley-Freeman, Gandhi, Greenblatt, Weintraub and Belcher.en_US
dc.subjectbuprenorphineen_US
dc.subjectmedication assisted treatmenten_US
dc.subjectopioid use disorderen_US
dc.subjectpatient satisfactionen_US
dc.subjectruralen_US
dc.subjecttelebehavioral healthen_US
dc.subjecttelemedicineen_US
dc.titlePatient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment.en_US
dc.typeArticleen_US
dc.identifier.doi10.3389/fpubh.2020.557275
dc.identifier.pmid33553083
dc.source.volume8
dc.source.beginpage557275
dc.source.endpage
dc.source.countrySwitzerland


This item appears in the following Collection(s)

Show simple item record